Follow-The-Filings

TELO Telomir Pharmaceuticals

Telomir Pharmaceuticals earnings company data as of 7:30 PM ET 8/20

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 13 Aug EPS -0.79
Rev

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
DEFA14A
10-Q
8-K 7.01,9.01
8-K 7.01,9.01
8-K 5.02,9.01
8-K 7.01,9.01
10-Q
8-K 8.01
8-K 1.01,2.01,3.02,9.01
8-K 8.01
8-K 8.01
8-K 5.02,5.03,5.07,9.01
10-K
DEFA14A
8-K 8.01
8-K 8.01
8-K 3.01
8-K 8.01
8-K 5.02
8-K 8.01
8-K 8.01
8-K 8.01
8-K 5.02,9.01
8-K 8.01
10-Q

Insider forms

Form 3 / 4 / 5 from EDGAR · 2 rows shown

Filed Form Detail Links
4 Period Apr 16, 2026 · 3 forms
4 Period May 21, 2026 · 2 forms

3 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice